Munafa Stock Market Course + Intraday & FNO calls 
Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Outlook Therapeutics (OTLK)
Technical Analysis Report for USA stock OTLK Outlook Therapeutics. Dated: 02 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock OTLK Outlook Therapeutics then click here. or read Experts views on Outlook Therapeutics or Forecast & share price targets of Outlook Therapeutics
Outlook Therapeutics Opened at 0.59 and Closed at: 0.59, which is 1.69% of previous session's close. It moved within a range of 0.57 and 0.61
The session was a Neutral session with an average volume of 5619500, which is -20.41% of previous session's volumes.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
A Dead cross was found 2 days back on short term averages
Support for tomorrow is 0.57 and resistance for tomorrow is 0.61
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.57, 0.55 resistance for tomorrow's hourly charts is 0.61, 0.63
10 Day SMA for Outlook Therapeutics (OTLK) is 0.64 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Outlook Therapeutics (OTLK) is 0.65 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Outlook Therapeutics (OTLK) is 0.77 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.95 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Outlook Therapeutics is 0.74 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Outlook Therapeutics is at 0.65 and 200 DMA is at 0.74, while 50 DMA and 100 DMA are at 0.77 and 0.95 respectively
Outlook Therapeutics (OTLK) moving average of 20 SMA is at 0.65 and 20 EMA is at 0.65
| Date | Closing Price | 20 SMA | 20 EMA |
| 02 Fri Oct | 0.59 | 0.65 | 0.65 |
| 01 Thu Oct | 0.58 | 0.65 | 0.66 |
| 30 Wed Sep | 0.57 | 0.65 | 0.67 |
| 29 Tue Sep | 0.63 | 0.65 | 0.68 |
| 28 Mon Sep | 0.62 | 0.65 | 0.69 |
| 25 Fri Sep | 0.65 | 0.66 | 0.7 |
Outlook Therapeutics (OTLK) moving average of 50 SMA is at 0.77 and 50 EMA is at 0.74
| Date | Closing Price | 50 SMA | 50 EMA |
| 02 Fri Oct | 0.59 | 0.77 | 0.74 |
| 01 Thu Oct | 0.58 | 0.78 | 0.75 |
| 30 Wed Sep | 0.57 | 0.8 | 0.76 |
| 29 Tue Sep | 0.63 | 0.81 | 0.77 |
| 28 Mon Sep | 0.62 | 0.83 | 0.78 |
| 25 Fri Sep | 0.65 | 0.84 | 0.79 |
Outlook Therapeutics (OTLK) moving average of 100 SMA is at 0.95 and 100 EMA is at 0.84
| Date | Closing Price | 100 SMA | 100 EMA |
| 02 Fri Oct | 0.59 | 0.95 | 0.84 |
| 01 Thu Oct | 0.58 | 0.94 | 0.85 |
| 30 Wed Sep | 0.57 | 0.94 | 0.86 |
| 29 Tue Sep | 0.63 | 0.94 | 0.87 |
| 28 Mon Sep | 0.62 | 0.93 | 0.87 |
| 25 Fri Sep | 0.65 | 0.93 | 0.87 |
Outlook Therapeutics (OTLK) moving average of 200 SMA is at 0.74 and 200 EMA is at 0.94
| Date | Closing Price | 200 SMA | 200 EMA |
| 02 Fri Oct | 0.59 | 0.74 | 0.94 |
| 01 Thu Oct | 0.58 | 0.75 | 0.94 |
| 30 Wed Sep | 0.57 | 0.76 | 0.94 |
| 29 Tue Sep | 0.63 | 0.76 | 0.94 |
| 28 Mon Sep | 0.62 | 0.77 | 0.94 |
| 25 Fri Sep | 0.65 | 0.78 | 0.94 |
Outlook Therapeutics has performed better than Tandem Diabetes in short term. Holding Outlook Therapeutics could be a better choice for now!
Repligen Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Repligen Corporation, about 20.35% more returns!
Phio Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 3.61% more returns!
Outlook Therapeutics has performed better than Pro Dex in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Ocular Therapeutix in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Meiragtx Holdings in short term. Holding Outlook Therapeutics could be a better choice for now!
Medpace Holdings has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Medpace Holdings, about 13.32% more returns!
Outlook Therapeutics has performed better than Inovio Pharmaceuticals in short term. Holding Outlook Therapeutics could be a better choice for now!
Eyegate Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 8.71% more returns!
Cytosorbents Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Cytosorbents Corporation, about 1036.94% more returns!
Outlook Therapeutics has performed better than Autolus Therapeutics in short term. Holding Outlook Therapeutics could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 10.39% more returns!
Outlook Therapeutics has performed better than Ascendis Pharma in short term. Holding Outlook Therapeutics could be a better choice for now!
Addus Homecare has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Addus Homecare, about 5.63% more returns!
Tenet Healthcare has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Tenet Healthcare, about 9.51% more returns!
Resmed Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Resmed Inc, about 7.8% more returns!
Outlook Therapeutics has performed better than Concord Medical in short term. Holding Outlook Therapeutics could be a better choice for now!
Brookdale Senior has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Brookdale Senior, about 4.21% more returns!
Becton Dickinson has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Becton Dickinson, about 7.64% more returns!
Outlook Therapeutics Technical analysis of indicators
Price action analysis of Outlook Therapeutics (OTLK) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.
Outlook Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Outlook Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Outlook Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.62 and Outlook Therapeutics OTLK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics OTLK stock. Volume based technical analysis of Outlook Therapeutics OTLK stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock OTLK Outlook Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And OTLK Experts View which covers a lot of information including buying and selling signals
OTLK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Outlook Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
